Literature DB >> 11385712

Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer.

O Caluseriu1, E L Cordisco, A Viel, S Majore, R Nascimbeni, S Pucciarelli, M Genuardi.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by mutations of genes encoding for proteins of the mismatch repair (MMR) machinery. The majority of mutations occur in the MLH1 and MSH2 genes, and consist of splice-site, frameshift and nonsense changes, leading to loss of protein function. In this study, we screened 7 HNPCC families for MLH1/MSH2 mutations. Sequence changes were identified in 5 families. Four alterations were novel 1- or 2-bp deletions or insertions causing a frameshift and appearance of premature stop codons (MLH1: c.597-598delGA, c.1520-1521insT; MSH2: c.1444delA, c.119delG). The four small insertions/ deletions were located within stretches of simple repeated sequences. By reviewing the HNPCC mutation database, we found that the majority of 1-2 bp frameshift mutations similarly affects simple repetitive stretches, pointing to DNA polymerase slippage during replication as the most likely source of such errors. We also evaluated microsatellite instability (MSI) in a breast carcinoma (BC) from an MLH1 mutation carrier. While a colon cancer from the same individual showed MSI, the BC specimen was MSI-negative, indicating that development of the latter tumor was unrelated to MMR impairment, despite presence of a constitutional MLH1 mutation. Hum Mutat 17:521, 2001. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385712     DOI: 10.1002/humu.1137

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.

Authors:  Michael D Walsh; Daniel D Buchanan; Margaret C Cummings; Sally-Ann Pearson; Sven T Arnold; Mark Clendenning; Rhiannon Walters; Diane M McKeone; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Kerry D Phillips; Graeme K Suthers; Jill George; Jack Goldblatt; Amanda Muir; Kathy Tucker; Elise Pelzer; Michael R Gattas; Sonja Woodall; Susan Parry; Finlay A Macrae; Robert W Haile; John A Baron; John D Potter; Loic Le Marchand; Bharati Bapat; Stephen N Thibodeau; Noralane M Lindor; Michael A McGuckin; Joanne P Young
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

2.  Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies.

Authors:  Ekatherina Sh Kuligina; Maxim Yu Grigoriev; Evgeny N Suspitsin; Konstantin G Buslov; Olga A Zaitseva; Olga S Yatsuk; Yulia R Lazareva; Alexandr V Togo; Evgeny N Imyanitov
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-10       Impact factor: 4.553

3.  Assay validation for identification of hereditary nonpolyposis colon cancer-causing mutations in mismatch repair genes MLH1, MSH2, and MSH6.

Authors:  Madhuri Hegde; Maria Blazo; Belinda Chong; Tom Prior; Carolyn Richards
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

4.  Familial breast and bowel cancer: does it exist?

Authors:  Rodney J Scott; Katie A Ashton
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

5.  Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.

Authors:  Michael D Walsh; Margaret C Cummings; Sally-Ann Pearson; Mark Clendenning; Rhiannon J Walters; Belinda Nagler; John L Hopper; Mark A Jenkins; Graeme K Suthers; Jack Goldblatt; Kathy Tucker; Michael R Gattas; Julie L Arnold; Susan Parry; Finlay A Macrae; Michael A McGuckin; Joanne P Young; Daniel D Buchanan
Journal:  Mod Pathol       Date:  2013-02-01       Impact factor: 7.842

6.  hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.

Authors:  A Apessos; M Mihalatos; I Danielidis; G Kallimanis; N J Agnantis; J K Triantafillidis; G Fountzilas; P A Kosmidis; E Razis; V A Georgoulias; G Nasioulas
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

7.  Novel Mutations in Serbian MEN1 Patients: Genotype-phenotype Correlation.

Authors:  Tatjana Isailovic; Ivana Milicevic; Djuro Macut; Milan Petakov; Sanja Ognjanovic; Bojana Popovic; Ivana Bozic Antic; Tamara Bogavac; Valentina Elezovic Kovacevic; Dusan Ilic; Svetozar Damjanovic
Journal:  J Med Biochem       Date:  2019-03-01       Impact factor: 3.402

Review 8.  Risk of breast cancer in Lynch syndrome: a systematic review.

Authors:  Aung Ko Win; Noralane M Lindor; Mark A Jenkins
Journal:  Breast Cancer Res       Date:  2013-03-19       Impact factor: 6.466

9.  Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.

Authors:  I Thiffault; N Hamel; T Pal; S McVety; V A Marcus; D Farber; S Cowie; J Deschênes; W Meschino; F Odefrey; D Goldgar; T Graham; S Narod; A K Watters; E MacNamara; D Du Sart; G Chong; W D Foulkes
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.